Metabolic effects of treatment with atypical antipsychotics

J Clin Psychiatry. 2004 Nov;65(11):1447-55. doi: 10.4088/jcp.v65n1102.
No abstract available

Publication types

  • Congress

MeSH terms

  • Adolescent
  • Adult
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / pharmacokinetics
  • Antipsychotic Agents / therapeutic use
  • Body Mass Index
  • Body Weight / drug effects
  • Child
  • Consensus Development Conferences as Topic
  • Diabetes Mellitus, Type 2 / chemically induced*
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetes Mellitus, Type 2 / metabolism
  • Drug Labeling / standards
  • Education, Medical, Continuing
  • Health Surveys
  • Humans
  • Hyperlipidemias / chemically induced*
  • Hyperlipidemias / epidemiology
  • Hyperlipidemias / metabolism
  • Obesity / chemically induced*
  • Obesity / epidemiology
  • Obesity / metabolism
  • Practice Guidelines as Topic
  • Prevalence
  • Psychotic Disorders / drug therapy
  • Psychotic Disorders / metabolism
  • Schizophrenia / drug therapy
  • Schizophrenia / metabolism
  • United States / epidemiology
  • United States Food and Drug Administration

Substances

  • Antipsychotic Agents